Bio-Rad expands instrument compatibility for new Cardiac Advance control
Bio-Rad Laboratories has expanded compatibility of its newest cardiac control, Cardiac Advance, to now include Beckman-Coulter instruments.
Designed to monitor the precision of instrument testing for cardiac events, this next generation control is optimized with Troponin I and T targets near the limit of instrument detection, adhering to the latest guidelines set by AACC and IFCC. In addition, Cardiac Advance control is consolidated with ten of the most tested cardiac analytes including Troponin, CK-MB, BNP/ProBNP, and Myoglobin
Cardiac Advance control is available in multiple formats including the standard Liquicheck human serum-based control as well as automation ready InteliQ and compact vial configurations designed to help streamline QC workflows to save time and resources.
Cardiac Advance controls are now compatible with Siemens, Roche, and Beckman-Coulter platforms and are available in the US, Europe, and select Asian markets.
For more information, visit: https://info.bio-rad.com/cardiac-markers.html
Digital issue: Please click here for more information
